The Pro Se Pilot Examination Unit Randomized Control Trial

How to cite

Pairolero, Nicholas; deGrazia, Charles; Pappas, Peter-Anthony; Toole, Andrew; Teodorescu, Mike. 2023. "The Pro Se Pilot Examination Unit Randomized Control Trial." AEA RCT Registry. AEARCTR-0011284. https://doi.org/10.1257/rct.11284-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Nicholas Pairolero* , Charles deGrazia , Peter-Anthony Pappas , Andrew Toole , Mike Teodorescu

* Primary investigator

Registry ID
AEARCTR-0011284
DOI
https://doi.org/10.1257/rct.11284-1.0
First registered
Last updated
Status
On going
Trial dates
2014-10-01 – 2025-01-01
Countries
Private
JEL codes
O31, O34
Registry record
http://www.socialscienceregistry.org/trials/11284

Abstract

In 2014, the USPTO established the Pro Se Pilot Examination Unit (PSPEU) to help inventors without legal representation (pro se inventors) as they went through the patent examination process by providing enhanced guidance and information. After stratifying by technology, pro se patent applications were randomly assigned to the treatment group, the PSPEU, or the control group, the regular examination process.

Intervention

The "treatment" is the additional guidance and information provided to applicants by PSPEU examiners relative to standard patent examiner practices given to applications in the control.

Experimental design

The USPTO designed the intervention as a randomized control trial, assigning incoming pro se patent applications randomly to either the treatment group, i.e., to the PSPEU, or the control group, the standard patent examination process. Since the USPTO does not collect information directly from applicants on whether they have legal representation, the PSPEU identified potential pro se applications using a search query executed on internal USPTO application data. The approach identified all applications that (1) were not yet assigned to an examiner, (2) did not have a power of attorney communication filed, and (3) were new applications, in the sense that the applications were not continuations, continuations in part, divisionals, reexaminations, requests for continued examination or reissues.

The RCT had two rounds. RCT Round 1 took place in October 2014, randomly assigning applications to either the treatment or control groups (using stratified randomization within the initial technology centers assigned to each application). RCT Round 2, which used the same assignment mechanism, was in October of 2015.

Design details

Randomization method
Within each technology center, applications were sorted by filing date (earliest first). Then, every other application, one to the treatment and one to the control, was assigned until the examiners in the PSPEU associated with that technology had full dockets of cases to be examined.
Randomization unit
Application
Clusters
2361
Observations
2361
Arms
1131 in treatment, 1230 in control
Primary outcomes
Receiving a patent
Secondary outcomes
Post-examination outcomes, including patent assignments, security interests and subsequently filed patent applications

Cited by

No citation data available for this registration yet.

Keywords